FDA Approved Medical Products for:
The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.
The FDA has approved this product to be used in this manner.
|For the use of Rituxan (rituximab) in combination with glucocorticoids for the treatment of pateints with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).|
|More Information about this product||
Drug Information Portal
Medline Plus Health Information